对美国毒物中心报告的急性水杨酸盐致死病例中水杨酸盐峰浓度的29年分析
该研究分析了1986年1月1日至2014年12月31日美国国家毒物数据系统(NPDS)报告的602例急性水杨酸盐致死病例,这些患者为急性水杨酸盐中毒是主要死因的住院期间死亡者。全年龄组平均报告的致死性水杨酸盐峰浓度为99.19 mg/dL(±50.2 mg/dL),中位数97.0 mg/dL。年龄最大四分位组(>57岁)平均浓度90.4 mg/dL,低于年龄最小四分位组(<30岁)的111.6 mg/dL(平均差21.2 mg/dL,95%CI 6.1-36.3)。有合并摄入者的平均浓度91.5 mg/dL,低于单纯水杨酸盐摄入者的104.8 mg/dL(平均差13.4 mg/dL,95%CI 21.4-5.3)。年龄增长和任何合并摄入与致死浓度呈负相关(估计值分别为0.41,95%CI 0.61-0.021;-14.43,95%CI 22.45-6.42)。当合并阿片类时,平均浓度为72.8 mg/dL(平均差32.1,95%CI 23.1-41.1)。结论指出,按现行100 mg/dL血透阈值,超过半数患者将被剥夺这一关键救命治疗,年龄增长和摄入其他物质(尤其是阿片类)与更低的致死峰浓度相关,需要前瞻性随机对照试验结合水杨酸盐浓度和其他临床因素为血透提供进一步指导。
要点
- 602例急性水杨酸盐致死病例的平均峰浓度为99.19 mg/dL(±50.2 mg/dL),中位数97.0 mg/dL。
- 年龄>57岁组平均致死峰浓度90.4 mg/dL,低于<30岁组的111.6 mg/dL(平均差21.2 mg/dL,95%CI 6.1-36.3)。
- 有合并摄入者平均致死峰浓度91.5 mg/dL,低于单纯水杨酸盐摄入者的104.8 mg/dL(平均差13.4 mg/dL,95%CI 21.4-5.3)。
- 合并阿片类摄入时平均致死峰浓度为72.8 mg/dL(平均差32.1,95%CI 23.1-41.1)。
- 按现行100 mg/dL血透阈值,超过半数致死病例的峰浓度低于该阈值。
适用人群与场景
- 1986年1月1日至2014年12月31日向美国国家毒物数据系统(NPDS)报告的急性水杨酸盐致死病例,限于住院期间死亡且急性水杨酸盐中毒是主要死因者,共602例。
研究设计与关键结果
- 研究类型为对NPDS 1986年1月1日至2014年12月31日数据的分析,纳入602例急性水杨酸盐致死病例。
- 全年龄组平均报告的致死性水杨酸盐峰浓度为99.19 mg/dL(±50.2 mg/dL),中位数为97.0 mg/dL。
- 年龄最大四分位组(>57岁)平均浓度90.4 mg/dL,低于年龄最小四分位组(<30岁)的111.6 mg/dL,平均差21.2 mg/dL(95%CI 6.1-36.3)。
- 有合并摄入者的平均浓度91.5 mg/dL,低于单纯水杨酸盐摄入者的104.8 mg/dL,平均差13.4 mg/dL(95%CI 21.4-5.3)。
- 年龄增长和任何合并摄入与致死浓度呈负相关(估计值0.41,95%CI 0.61-0.021;估计值-14.43,95%CI 22.45-6.42)。
- 合并阿片类摄入时平均浓度72.8 mg/dL,平均差32.1(95%CI 23.1-41.1)。
证据类型、等级与局限
- 证据类型:对毒物中心数据的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,按现行100 mg/dL血透阈值,超过半数患者将被剥夺这一关键救命治疗。
- 作者认为,年龄增长和摄入其他物质(尤其是阿片类)与更低的致死峰浓度相关。
- 作者认为,需要前瞻性随机对照试验结合水杨酸盐浓度和其他临床因素为血透提供进一步指导。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND/OBJECTIVES: The threshold salicylate concentration commonly recommended to initiate extracorporeal elimination, in the absence of significant end-organ toxicity, is 100 mg/dL. Unfortunately, the grade of evidence to support this decision is low. Our primary aim is to describe highest reported salicylate concentrations in patients who died from acute salicylate ingestions. Our secondary aim is to determine if age or coingestants varied with highest reported salicylate concentration.
METHODS: We analyzed acute salicylate fatalities reported to the National Poison Data System (NPDS) between 1 January 1986 and 31 December 2014. Included were patients who died during the index hospitalization and for which acute salicylate toxicity was the primary cause of death. We used descriptive statistics with standard deviations (SD) or 95% confidence intervals (CI) where appropriate. We created a general linear model that evaluated the association of age and coingestions with salicylate concentrations. We divided the patients into age quartiles to assess a possible interaction between age and salicylate concentration.
RESULTS: We identified 602 acute salicylate fatalities that fit inclusion criteria. The mean peak reported fatal salicylate concentration across all age groups was 99.19 mg/dL (± 50.2 mg/dL). The median peak fatal salicylate concentration was 97.0 mg/dL. The oldest quartile had a lower mean concentration (age >57 years; 90.4 mg/dL) than the youngest quartile (age <30 years; 111.6 mg/dL, mean difference 21.2 mg/dL, 95%CI 6.1-36.3). Fatalities with a coingestant had a lower mean concentration of 91.5 mg/dL compared to 104.8 mg/dL among those ingesting salicylates alone (mean difference 13.4 mg/dL, 95%CI 21.4-5.3). Increasing age and the presence of any coingestions were negatively associated with fatal concentrations (estimates; 95%CI 0.41; 0.61-0.021 and -14.43; 22.45-6.42, respectively). When opioids were a coingestant, mean concentration was 72.8 (mean difference 32.1 95%CI 23.1-41.1).
CONCLUSIONS: Using the current recommended hemodialysis threshold of 100 mg/dL, more than half of the patients would be deprived of this critical life-saving therapy. Additionally, increasing age and ingestion of other substances, especially opioids, are associated with lower peak fatal salicylate concentrations. A prospective, randomized controlled trial considering salicylate concentrations and other clinical factors may provide further guidance for hemodialysis.
参考来源
- Warrick BJ, King A, Smolinske S, et al. A 29-year analysis of acute peak salicylate concentrations in fatalities reported to United States poison centers. Clin Toxicol (Phila). 2018. PMID: 29431532. doi:10.1080/15563650.2018.1435887
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。